Literature DB >> 11465949

TNF-alpha receptor 1 (p55) on islets is necessary for the expression of LIGHT on diabetogenic T cells.

S V Pakala1, A Ilic, L Chen, N Sarvetnick.   

Abstract

Insulin-dependent diabetes mellitus results from T-cell-mediated destruction of pancreatic islet beta cells. Both CD4 and CD8 T cells have been shown to be independently capable of beta cell destruction. However, the mechanism of beta cell destruction has remained elusive. It has previously been shown that the absence of TNF-alpha receptor 1 (p55) on the islets protected islets from CD4 T-cell-mediated destruction as long as the T cells did not have access to wild-type islets in vivo. Wild-type and TNF-alpha receptor 1 (p55) deficient islets induce similar levels of proliferation of BDC2.5 T cells. In this study, we demonstrate that islet TNF-alpha receptor 1 (p55) influences the expression of LIGHT (TNFSF-14), a TNF family member with both cytolytic and costimulatory properties, on BDC2.5 T cells and the expression of its receptor HVEM (TNFRSF-14) by islets, indicating a role for LIGHT-HVEM interactions in autoimmune diabetes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465949     DOI: 10.1006/clim.2001.5059

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  4 in total

Review 1.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.

Authors:  Marcos W Steinberg; Jr-Wen Shui; Carl F Ware; Mitchell Kronenberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

2.  Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes.

Authors:  Natasha J Hill; Aleksandr Stotland; Michelle Solomon; Patrick Secrest; Elizabeth Getzoff; Nora Sarvetnick
Journal:  Biol Direct       Date:  2007-01-25       Impact factor: 4.540

3.  Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma.

Authors:  Eun-Hee Lee; Eun-Mi Kim; Kon-Young Ji; A-Reum Park; Ha-Rim Choi; Hwa-Youn Lee; Su-Man Kim; Byung Yeoup Chung; Chul-Hong Park; Hyo Jin Choi; Young-Hyeh Ko; Hyoung-Woo Bai; Hyung-Sik Kang
Journal:  Oncotarget       Date:  2017-03-28

4.  A crucial role for HVEM and BTLA in preventing intestinal inflammation.

Authors:  Marcos W Steinberg; Olga Turovskaya; Raziya B Shaikh; Gisen Kim; Declan F McCole; Klaus Pfeffer; Kenneth M Murphy; Carl F Ware; Mitchell Kronenberg
Journal:  J Exp Med       Date:  2008-06-02       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.